Back

The beneficial effects of sodium glucose co-transporter-2 inhibitor in type 2 diabetes patients with multiple risk factors needs to be explored further: a meta-analysis

13 April 2023 (16:35 - 17:10)
Organised by:
Congress Presentation Part of: Moderated ePoster 31 Cardiovascular Disease in Special Populations, Other EAPC Premium Access ESC Preventive Cardiology 2023

About the speaker

Photo
Professor Samit Ghosal

Nightingale Hospital, Kolkata (India)

5 More presentations in this session

Presentation thumbnail
The effects of cardiovascular rehabilitation in patients with coronary artery disease with or without diabetes assessed by thoracic bioimpedance - do they benefit equally?
Doctor M. Stojanovic (Niska Banja, RS)
Presentation thumbnail
Associations between exercise training characteristics and change in peak oxygen consumption in patients with chronic ischaemic heart disease and type 2 diabetes
Mr F. Gass (Munich, DE)
Abstract Slides
Presentation thumbnail
Trends in diabetes mellitus among hospital hospitalizations in Switzerland
Professor P. Marques-Vidal (Lausanne, CH)
Abstract Slides
Presentation thumbnail
Prevention of metabolic syndrome implies prevention of severe and multivessel coronary artery disease.
Doctor I. Vogiatzis (Veria, GR)
Abstract Slides
Presentation thumbnail
Cardiac pre-participation evaluation in adolescent male basketball athletes in Brazil
Doctor C. Colombo (Valinhos, BR)
Slides

Access the full session

Session thumbnail
Moderated ePoster 31

The Event

Event poster

ESC Preventive Cardiology 2023

13 April 2023 16:35 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources